Top Markets
#1 Bedrock Bedrock +54.89%
#2 Naoris Protocol Naoris Protocol +20.56%
#3 IQ IQ +19.64%
#4 pippin pippin +18.04%
#5 Irys Irys +17.34%
#6 パンチ (Punch) パンチ (Punch) +13.44%
#7 ETHGas ETHGas +13.37%
#8 Bitway Bitway +12.92%
#9 Magma Finance Magma Finance +12.90%
#10 Aria.AI Aria.AI +12.61%
Coin of the day
Bedrock Bedrock
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rang in Aktien #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Aktienkurs
$0.16328419
Marktkapitalisierung
$204.14K
Veränderung (1 Tag)
4.35%
Veränderung (1 Jahr)
102.45%
Land
GB
Handel Fusion Antibodies plc (FAB)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Fusion Antibodies plc (FAB)
Dividendenrendite (TTM) von Fusion Antibodies plc (Aktienkürzel: FAB) zum 2024-03-31: 0.00%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Fusion Antibodies plc (FAB) von 2013 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.72%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
0.48%
US
UCB SA UCB SA
UCB SA
UCB.BR
0.48%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL